SCHEMBL29581099

SCHEMBL29581099

O=C(Nc1ccncc1)c1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.64
RAB9A P51151 6/20 0.64
SMN1; SMN2 Q16637 6/20 0.64
GRM4 Q14833 4/20 0.64
PKM P14618 3/20 0.64
KDR P35968 3/20 0.64
MAPT P10636 2/20 0.64
JAK2 O60674 2/20 0.62
TYK2 P29597 2/20 0.62
HDAC6 Q9UBN7 1/20 0.61
KDM4E B2RXH2 2/20 0.60
MITF O75030 1/20 0.60
LMNA P02545 1/20 0.60
KCNK3 O14649 1/20 0.59
KCNK9 Q9NPC2 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.58
HTT P42858 2/20 0.58
TP53 P04637 1/20 0.57
MAPK1 P28482 1/20 0.57
KLF5 Q13887 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12469044 1.00 NPC1 (0.64) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL30210285 0.93 NPC1 (0.61) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL231897 0.89 KDR (0.78) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL29184186 0.87 KDR (0.76) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL28947571 0.84 NPC1 (0.67) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL5898991 0.82 GRM4 (0.60) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL10415452 0.82 GRM4 (0.65) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL6037590 0.82 KDR (0.78) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL20990144 0.82 NPC1 (0.67) NPC1RAB9ASMN1; SMN2GRM4PKM
SCHEMBL6037587 0.82 NPC1 (0.65) NPC1RAB9ASMN1; SMN2GRM4PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 CN claimed
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 EP claimed
CN-117843566-A Polysubstituted benzene derivative, composition and use thereof 康迈迪森(北京)医药科技有限公司 2024-04-09 CN disclosed
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 CN disclosed
EP-3617196-B1 N-(4-PYRIDYL) NICOTINAMIDE COMPOUND OR SALT THEREOF ISHIHARA SANGYO KAISHA (JP) 2023-06-07 EP disclosed
CN-111732548-B N2-carbamyl aromatic ring-2-aminopyrimidine derivatives and medical application thereof 浙江大学 2022-06-17 CN disclosed